Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD
Clinical trial NCT06345404 · COMPLETED
Trial details
- NCT number
- NCT06345404
- Sponsor
- Corvus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-16
- Primary completion
- 2026-01-28
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.